162 related articles for article (PubMed ID: 11604994)
1. Effects of retinoic acid and interferon-gamma on expression of the retinoic acid receptor in mouse renal cell carcinoma.
Hara I; Taguchi I; Miyake H; Hara S; Gotoh A; Kamidono S
Int J Oncol; 2001 Nov; 19(5):959-62. PubMed ID: 11604994
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anti-tumor effect of 13-cRA and IFN-alpha/beta in mouse renal cell carcinoma.
Taguchi I; Hara I; Gohji K; Arakawa S; Kamidono S
Int J Oncol; 1998 Jul; 13(1):145-9. PubMed ID: 9625816
[TBL] [Abstract][Full Text] [Related]
3. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
Motzer RJ; Schwartz L; Law TM; Murphy BA; Hoffman AD; Albino AP; Vlamis V; Nanus DM
J Clin Oncol; 1995 Aug; 13(8):1950-7. PubMed ID: 7636535
[TBL] [Abstract][Full Text] [Related]
4. Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid.
Hoffman AD; Engelstein D; Bogenrieder T; Papandreou CN; Steckelman E; Dave A; Motzer RJ; Dmitrovsky E; Albino AP; Nanus DM
Clin Cancer Res; 1996 Jun; 2(6):1077-82. PubMed ID: 9816270
[TBL] [Abstract][Full Text] [Related]
5. Enhanced apoptosis and radiosensitization by combined 13-cis-retinoic acid and interferon-alpha2a; role of RAR-beta gene.
Ryu S; Stein JP; Chung CT; Lee YJ; Kim JH
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):785-90. PubMed ID: 11697325
[TBL] [Abstract][Full Text] [Related]
6. Effects of all-trans retinoic acid and interferon-gamma on expression of RAR beta gene in Tca8113 cells.
Chen WT; He RG; Liu XK; Zhou XJ
Chin J Dent Res; 1999 Dec; 2(3-4):25-30. PubMed ID: 10863413
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a.
Berg WJ; Nanus DM; Leung A; Brown KT; Hutchinson B; Mazumdar M; Xu XC; Lotan R; Reuter VE; Motzer RJ
Clin Cancer Res; 1999 Jul; 5(7):1671-5. PubMed ID: 10430067
[TBL] [Abstract][Full Text] [Related]
8. Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells.
Widschwendter M; Daxenbichler G; Dapunt O; Marth C
Cancer Res; 1995 May; 55(10):2135-9. PubMed ID: 7743514
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma.
Wang XF; Qian DZ; Ren M; Kato Y; Wei Y; Zhang L; Fansler Z; Clark D; Nakanishi O; Pili R
Clin Cancer Res; 2005 May; 11(9):3535-42. PubMed ID: 15867257
[TBL] [Abstract][Full Text] [Related]
10. Interaction of retinoic acid and interferon in renal cancer cell lines.
Nanus DM; Geng Y; Shen R; Lai HK; Pfeffer SR; Pfeffer LM
J Interferon Cytokine Res; 2000 Sep; 20(9):787-94. PubMed ID: 11032398
[TBL] [Abstract][Full Text] [Related]
11. All-trans retinoic acid and interferon-alpha for treatment of human renal cell carcinoma multicellular tumor spheroids.
Rohde D; Brkovic D; Hönig d'Orville I
Urol Int; 2004; 73(1):47-53. PubMed ID: 15263793
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).
Aass N; De Mulder PH; Mickisch GH; Mulders P; van Oosterom AT; van Poppel H; Fossa SD; de Prijck L; Sylvester RJ
J Clin Oncol; 2005 Jun; 23(18):4172-8. PubMed ID: 15961764
[TBL] [Abstract][Full Text] [Related]
14. Interferons induce normal and aberrant retinoic-acid receptors type alpha in acute promyelocytic leukemia cells: potentiation of the induction of retinoid-dependent differentiation markers.
Gianní M; Zanotta S; Terao M; Rambaldi A; Garattini E
Int J Cancer; 1996 Sep; 68(1):75-83. PubMed ID: 8895544
[TBL] [Abstract][Full Text] [Related]
15. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
Wan H; Hong WK; Lotan R
Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lung metastases of murine renal cell carcinoma by the combination of radiation and interferon-alpha-producing tumor cell vaccine.
Nishisaka N; Jones RF; Morse P; Kuratsukuri K; Romanowski R; Wang CY; Haas GP
Cytokines Cell Mol Ther; 2000 Dec; 6(4):199-206. PubMed ID: 11565958
[TBL] [Abstract][Full Text] [Related]
17. Effect of interferon-alpha A/D in combination with the Japanese and Chinese traditional herbal medicine juzen-taiho-to on lung metastasis of murine renal cell carcinoma.
Muraishi Y; Mitani N; Yamaura T; Fuse H; Saiki I
Anticancer Res; 2000; 20(5A):2931-7. PubMed ID: 11062703
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cDNAs encoding two chick retinoic acid receptor alpha isoforms and distribution of retinoic acid receptor alpha, beta and gamma transcripts during chick skin development.
Michaille JJ; Kanzler B; Blanchet S; Garnier JM; Dhouailly D
Int J Dev Biol; 1995 Aug; 39(4):587-96. PubMed ID: 8619957
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid inhibits the growth of human myeloma cells in vitro.
Palumbo A; Battaglio S; Napoli P; Bruno B; Omedè P; Boccadoro M; Pileri A
Br J Haematol; 1995 Mar; 89(3):555-60. PubMed ID: 7734354
[TBL] [Abstract][Full Text] [Related]
20. Activity of ALRT 1550, a new retinoid, with interferon-gamma on ovarian cancer cell lines.
Hu W; Verschraegen CF; Wu WG; Nash M; Freedman RS; Kudelka A; Kavanagh JJ
Int J Gynecol Cancer; 2002; 12(2):202-7. PubMed ID: 11975681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
